These results pinpointed that in humans with T2D, a fraction of β-cells (LDHA-positive cells overlapping with cluster 7 β-cells) possess a genetic signature with reduced INS and increased GCG and ARX expression. The gene discussed is INS; the disease is type 2 diabetes mellitus.